-
From Danielle Solar on September 9th, 2020
| 10 10 playsDr. Jackson teaches human biology in the department of Natural and Applied Sciences. They quickly updated the course to reflect the pandemic during the spring semester… -
From Danielle Solar on September 9th, 2020
| 7 7 playsFred Ledley explains the Center for Integration of Science's current research around "the financing and public policy related to drug development" as it… -
From Danielle Solar on September 9th, 2020
| 3 3 playsMatthew Jackson works in the Center for Integration of Science and Industry on the maturity of underlying basic research, funding and drug development. Dr. Jackson is… -
From Media User on November 19th, 2019
| 51 51 playsDr. Edward J. Benz, Jr., MD, former president and CEO of Dana-Farber Cancer Institute talks about Dana Farber’s role in healthcare innovation and how this large… -
From Media User on November 14th, 2019
| 36 36 playsA fireside chat on the financialization of the pharmaceutical industry and its effects on drugs by Economist Dr. William Lazonick. The event is organized by the Center… -
From KalturaMediaUser MediaUser on March 12th, 2019
| 20 20 playsA fireside chat with Dr. Gary J. Nabel, M.D., Ph.D. Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North… -
From KalturaMediaUser MediaUser on November 1st, 2018
| 87 87 playsDr. Sharp will explore the dynamic intersections of science with business and public policy, and how these interactions advance the public interest. We are honored to… -
From Media User on April 26th, 2018
| 42 42 playsEkaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark… -
From Media User on April 4th, 2018
| 59 59 playsBentley alumnus Lance Colwell, and MIldon Farrwell, from Biogen, discuss the commercial launch of a revolutionary new product, Spiranza -
From KalturaMediaUser MediaUser on February 23rd, 2018
| 47 47 playsStephen Bonner, former CEO & Director, Center Treatment Centers of America